Computational platform for modelling, analysis, and prediction of anti-EGFR drug resistance for lung cancer

被引：0
|
作者：
Yan, H. [1 ]
Zhu, G. Y. [2 ]
Wong, M. [3 ]
Lee, V [4 ]
机构：
[1] City Univ Hong Kong, Dept Elect Engn, Hong Kong, Peoples R China
[2] City Univ Hong Kong, Dept Chem, Hong Kong, Peoples R China
[3] Univ Hong Kong, Li Ka Shing Fac Med, Dept Pathol, Hong Kong, Peoples R China
[4] Univ Hong Kong, Li Ka Shing Fac Med, Dept Clin Oncol, Hong Kong, Peoples R China
来源：
HONG KONG MEDICAL JOURNAL | 2019年 / 25卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：40 / 42
页数：3
相关论文
共 50 条
  • [41] Blockade of EGFR and MEK Intercepts Heterogeneous Mechanisms of Acquired Resistance to Anti-EGFR Therapies in Colorectal Cancer
    Misale, Sandra
    Arena, Sabrina
    Lamba, Simona
    Siravegna, Giulia
    Lallo, Alice
    Hobor, Sebastijan
    Russo, Mariangela
    Buscarino, Michela
    Lazzari, Luca
    Sartore-Bianchi, Andrea
    Bencardino, Katia
    Amatu, Alessio
    Lauricella, Calogero
    Valtorta, Emanuele
    Siena, Salvatore
    Di Nicolantonio, Federica
    Bardelli, Alberto
    SCIENCE TRANSLATIONAL MEDICINE, 2014, 6 (224)
  • [42] Unexpected insights for anti-EGFR cancer therapy
    Depeille, Philippe
    Warren, Robert S.
    Roose, Jeroen P.
    ONCOTARGET, 2015, 6 (22) : 18746 - 18747
  • [43] Optimizing Anti-EGFR Strategies in Cancer Treatment
    Toschi, Luca
    Finocchiaro, Giovanna
    Garassino, Isabella
    De Vincenzo, Fabio
    Campagnoli, Elisabetta
    Ceresoli, Giovanni Luca
    Cavina, Raffaele
    Zucali, Paolo Andrea
    Santoro, Armando
    Cappuzzo, Federico
    CURRENT CANCER THERAPY REVIEWS, 2007, 3 (04) : 267 - 275
  • [44] Optimizing Anti-EGFR Therapy in Colorectal Cancer
    Salazar, Ramon
    Ciardiello, Fortunato
    CLINICAL CANCER RESEARCH, 2015, 21 (24) : 5415 - 5416
  • [45] Molecular Pathways: Sensitivity and Resistance to Anti-EGFR Antibodies
    Bertotti, Andrea
    Sassi, Francesco
    CLINICAL CANCER RESEARCH, 2015, 21 (15) : 3377 - 3383
  • [46] Targeting Autophagy for Overcoming Resistance to Anti-EGFR Treatments
    Kwon, Yoojung
    Kim, Misun
    Jung, Hyun Suk
    Kim, Youngmi
    Jeoung, Dooil
    CANCERS, 2019, 11 (09)
  • [47] Increased Detection Sensitivity for KRAS Mutations Enhances the Prediction of Anti-EGFR Monoclonal Antibody Resistance in Metastatic Colorectal Cancer
    Molinari, Francesca
    Felicioni, Lara
    Buscarino, Michela
    De Dosso, Sara
    Buttitta, Fiamma
    Malatesta, Sara
    Movilia, Alessandra
    Luoni, Marco
    Boldorini, Renzo
    Alabiso, Oscar
    Girlando, Salvatore
    Soini, Barbara
    Spitale, Alessandra
    Di Nicolantonio, Federica
    Saletti, Piercarlo
    Crippa, Stefano
    Mazzucchelli, Luca
    Marchetti, Antonio
    Bardelli, Alberto
    Frattini, Milo
    CLINICAL CANCER RESEARCH, 2011, 17 (14) : 4901 - 4914
  • [48] KRAS MUTATIONS UNDERLIE RESISTANCE TO ANTI-EGFR ANTIBODIES
    不详
    CANCER DISCOVERY, 2012, 2 (08) : 663 - 663
  • [49] Transformation of adenocarcinoma into small cell lung cancer as one of the mechanisms of acquired resistance to anti-EGFR tyrosine kinase inhibitors
    Kovalov, O. O.
    Tolok, O. P.
    Kovalov, K. O.
    PATHOLOGIA, 2024, 21 (01): : 84 - 88
  • [50] ROLE OF THE HEDGEHOG PATHWAY IN MEDIATING RESISTANCE TO ANTI-EGFR TYROSINE KINASE INHIBITORS IN NON SMALL CELL LUNG CANCER
    Morgillo, F.
    Della Corte, C. M.
    Martini, G.
    Manzo, A.
    Gambardella, V.
    Vitagliano, D.
    Martinelli, E.
    Troiani, T.
    Ciardiello, F.
    ANNALS OF ONCOLOGY, 2012, 23 : 430 - 430
12345